openPR Logo
Press release

MEDraysintell releases its Proton Therapy Market Essentials report 2017

01-31-2017 09:44 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: MEDraysintell

MEDraysintell

MEDraysintell

MEDraysintell publishes its new “Proton Therapy Market Essentials” report providing key facts and figures on Proton Therapy to advice non-industry insiders on the potential for investments, market development, merger and acquisitions (M&A) existing in this healthcare technology.

This “Proton Therapy Market Essentials” report will be a real asset for institutions looking to implement a new proton therapy center and for the financial community (investors, investment bankers and M&A professionals) to support their audit and to make informed decisions with unbiased and factual intelligence from experts.

This condensed report, with over 30 tables and figures, provides the most accurate and up-to-date information related to the proton therapy industry. It includes important insights on the market, analyzing past evolutions and future trends to the year 2030, key drivers and vendors, mostly in tabulated forms with the most recent and precise figures and names. It covers also carbon therapy.

The report is available at the price of EUR 600.
Contact Paul-Emmanuel Goethals for information and to order:
peg@medraysintell.com or +32 491 080 968

MEDraysintell believes it is the right moment to publish such a “Market Essentials” report as proton therapy has entered an era of high potential for growth and becomes a real part of the global radiotherapy world. Most proton therapy vendors already have, or are developing a compact proton therapy system which, along with a growing number of clinical evidence regarding its efficacy, will drive proton therapy to be used to treat a broader number of patients.

MEDraysintell has already supported numerous companies globally helping them to better understand these markets, and welcomes your requests for specific intelligence needs in these areas.

About MEDraysintell
Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors!

MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, radiotherapy, proton therapy and brachytherapy.
We offer the most comprehensive set of reports and directories, with over 1,900 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment. We offer client-specific intelligence in the field of radiation healthcare, with the upmost knowledge leveraging our extended network of worldwide contacts. We are proud to support numerous companies globally, helping them better understand the markets, competitive environment as well as the potential of merger and acquisitions (M&A) and technology development. We have repeat satisfied clients operating in the field of medical radiation, investment banks and institutional investors, large international consulting firms and universities research laboratories.
MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann. It combines over 40 years of experience in radiation healthcare. www.medraysintell.com

Paul-Emmanuel Goethals, MBA
Chemin du Cyclotron, 6
1348 Louvain-la-Neuve, Belgium
peg@medraysintell.com
Mobile: +32 491 080 968

Richard Zimmermann, PhD
Lalaye, France
rz@medraysintell.com
Mobile: +33 6 82 80 06 00

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MEDraysintell releases its Proton Therapy Market Essentials report 2017 here

News-ID: 424459 • Views:

More Releases from MEDraysintell

Proton Therapy Industry, a first consolidation in a niche market
Proton Therapy Industry, a first consolidation in a niche market
With the recent announcement of Hitachi to acquire the particle therapy business of Mitsubishi, we observe the first consolidation in the PT industry. Following this recent announcement, the top three vendors share now 70% of the PT market in 2017 valued at US$ 0.9 billion. Several companies are expected to enter the market for the first time in the coming years with their own PT systems. The global PT market
MEDraysintell downgrades its proton therapy market projection
MEDraysintell downgrades its proton therapy market projection
In light of several factors summarized below, MEDraysintell is downgrading its proton therapy market projection from 1,200 proton therapy treatment rooms that were expected to be operational in 2030 to 900. This still represents a 12% annual growth from 2017 to 2030 and the need to open an average of more than 50 PT treatment rooms every year from 2018 to 2030. Originally MEDraysintell expected 2015 to become the starting point
Future and Economics of Nuclear Medicine
Future and Economics of Nuclear Medicine
Need to understand future and economics of Nuclear Medicine? Looking for experts in this field? Trying to appreciate the potential of this new technology? MEDraysintell will display its series of market reports and directories with over 2,100 pages of unrivaled intelligence covering Nuclear Medicine, Cyclotrons, Brachytherapy and Proton Therapy, during the EANM – European Association of Nuclear Medicine – congress (Vienna, Austria, October 21-25, 2017). MEDraysintell is gratefully hosted by the
Impulse from radiotherapeutics confirms accelerated growth of nuclear medicine
Impulse from radiotherapeutics confirms accelerated growth of nuclear medicine
MEDraysintell releases its new Nuclear Medicine World Market Report and Directory–Edition 2017, a 1,100-page document that provides an exhaustive description and analysis of more than 390 products, including over 140 radiopharmaceuticals under clinical development, with a comprehensive profile of 193 companies and institutions active in the radiopharmaceuticals industry. Detailed table of contents and sample pages available upon request a peg@medraysintell.com MEDraysintell estimates that the global market for nuclear medicine reached US$ 4.5

All 5 Releases


More Releases for Proton

Proton Pure Air Purifier: Read Our Proton Pure Reviews
Proton pure air purifier is a device invented in the United States that uses carbon filters and a High-Efficiency Particulate Air Filter to precisely clean and minimizes pollutants by up to 99.7%. (HEPA). This gadget fits in rooms up to 350 square feet, reduces the danger of allergies and sickness, and increases the flow of air in and out of the space. Dust, pollen, mold, animal hair, germs, and other
Proton therapy market
Global Proton therapy market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). Proton therapy is the most precise and advanced form of radiation therapy and is mainly used in the treatment of cancer. It
Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Th …
"The Report Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast is a research study published by Renub Research. According to this research South Korea Proton Therapy Market is expected to almost triple by
Proton Therapy Market in Switzerland, Reimbursement Policy, Patients Treated at …
"The Report Proton Therapy Market in Switzerland, Reimbursement Policy, Patients Treated at Proton Facility & Forecast provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Switzerland has one of the old proton therapy centers in Europe and was established in 1984 and there are so many recommended proton therapy patients from other parts of Europe coming for their treatment. The old proton
Korea Proton Therapy Market, Reimbursement Policy, Patients Treated At Proton Th …
Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast is a research study published by Renub Research. According to this research South Korea Proton Therapy Market is expected to almost triple by 2021 from its current market size in 2016. Untapped Proton Therapy Market for South Korea was more than 1 Billion USD in period of 2016. Proton Therapy plays an important role in delivering
Proton Therapy Market In Switzerland, Reimbursement Policy, Patients Treated At …
Switzerland has one of the old proton therapy centers in Europe and was established in 1984 and there are so many recommended proton therapy patients from other parts of Europe coming for their treatment. The old proton therapy center at CPT, PSI, Villigen was further renovated with technological advancement in 2010 and again in 2013. Switzerland Proton Therapy Market is expected to grow thrice from its present market in 2016.